Evidence map›Paper›PMID 30680884›Full record

ArticleJournal of applied clinical medical physics2019

Customized double-shell immobilization device combined with VMAT radiation treatment of basosquamous cell carcinoma of the scalp.

Noor Mail, Suliman M Al-Ghamdi, Carelse Chantel, Farid Sedhu, Atique Rana, Abdelhamid Saoudi

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of applied clinical medical physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Noor MailKing Abdullah International Medical Research Center (KAIMRC)/King Saud bin Abdulaziz University for Health Science, Ministry of National Guard Health Affair, Jeddah, Saudi Arabia.
Suliman M Al-GhamdiKing Abdullah International Medical Research Center (KAIMRC)/King Saud bin Abdulaziz University for Health Science, Ministry of National Guard Health Affair, Jeddah, Saudi Arabia.
Carelse ChantelPrincess Norah Oncology Center (PNOC), Department of Radiation Oncology, King Abdulaziz Medical City, Ministry of National Guard Health Affair, Jeddah, Saudi Arabia.
Farid SedhuPrincess Norah Oncology Center (PNOC), Department of Radiation Oncology, King Abdulaziz Medical City, Ministry of National Guard Health Affair, Jeddah, Saudi Arabia.
Atique RanaPrincess Norah Oncology Center (PNOC), Department of Radiation Oncology, King Abdulaziz Medical City, Ministry of National Guard Health Affair, Jeddah, Saudi Arabia.
Abdelhamid SaoudiKing Abdullah International Medical Research Center (KAIMRC)/King Saud bin Abdulaziz University for Health Science, Ministry of National Guard Health Affair, Jeddah, Saudi Arabia.
King Abdulaziz Medical City · SAKing Abdullah International Medical Research Center · SANational Guard Health Affairs · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignancies with a superficial involvement of the scalp/skull present technical challenges for radiation-treatment-planning, such as achieving skin coverage with the prescribed dose and with the desirable conformity, homogeneity, and lower brain dose. We report a radiotherapy treatment technique for a patient diagnosed with diffuse basosquamous cell carcinoma of the scalp and adjacent skull-bone. This study presents the plan's quality parameters, patient's dosimetry, and patient's outcome. The patient was treated using volume-modulated-arc therapy (VMAT) and a double-shell-bolus full-head device (DSBFD) designed for patient immobilization and better skin coverage. A VMAT plan was generated using an Eclipse treatment-planning system for a prescribed dose of 60 Gy in 30 fractions. The treatment plan was analyzed to determine the conformity index (CI), the homogeneity index (HI), the target-coverage, and the dose to the organs-at-risk (OARs). Skin-doses were measured using optically stimulated luminescence (OSL) dosimeters. Clinical follow-up was performed by the radiation oncologist during and after the course of radiotherapy. With regard to planning target volume (PTV) coverage, the V

Indexed as

Bone NeoplasmsCarcinoma, BasosquamousFemaleHumansImmobilizationMiddle AgedOrgans at RiskPrognosisRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedScalpdouble-shell-bolusin vivo dosimetryplan quality parameterstreatment outcome

Identifiers

PMID30680884
PMCPMC6370993
OpenAlexW2911832594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.